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Despite the progress made in reducing fertility and increasing the contraceptive prevalence rate 
(CPR) in Kenya, many women still experience a high unmet need for contraception. Part of the 
challenge in addressing current levels of unmet need is the limited use of contraception by women 
during the first 12 months postpartum. New methods are needed that offer greater ease of use, that 
are women-initiated, and that do not require significant health infrastructure or medical provider 
involvement for service delivery. One such method is the Progesterone Vaginal Ring (PVR), a user-
initiated, reversible contraceptive that according to clinical trial data is safe and effective for 
breastfeeding women.  
New product introduction strategies often suffer from lack of available market research and rely on 
hypothetical approaches to gauge consumer demand and provider readiness to offer services. The 
PVR, a new product in sub-Saharan Africa, faced such a challenge. For this reason, we determined 
that a study on Willingness to Pay (WTP) was necessary to estimate the effect of price on potential 
consumer demand for the method in Kenya. 
The specific objectives of the study were to: (1) assess the willingness to pay for the PVR among 
potential users (women seeking family planning services at health facilities); (2) assess the 
willingness among health care providers (in public, private nonprofit, and private commercial 
sectors) to counsel on and offer the PVR to users; and (3) assess the willingness to procure the PVR 
among potential suppliers, including the government and donors. The study was conducted in 
Nairobi County between March and June 2015. The following are the main findings:  
 Women seeking family planning services at public, private nonprofit, and private commercial 
facilities are willing to pay for the PVR if it is available. A significant proportion of women who 
visit the private commercial sector spend 50–199 Kenya shillings (KES) (US$0.5–$2) per 
month on family planning (FP) services and products. This implies that a market currently 
exists for family planning products through the private commercial sector. 
 The majority of respondents were willing to pay a price equivalent to a three-month supply of 
Progestogen-only pills (POP) plus a 10% increment on that price, with some variation across 
sectors. Respondents from public sector facilities were more sensitive to marginal price 
increments than those who were interviewed at private sector facilities.   
 Nearly universally, health care providers (based in public, private nonprofit, and private 
commercial facilities) indicated that the PVR is an important option to include in the choice 
of methods, especially in light of the frequent and prolonged stock-out of Microlut 
contraceptive pills. They are willing to counsel and provide the PVR to users. Providers in the 
public and private nonprofit sectors suggested a median price of KES100 (US$1) and those 
in the private commercial sector proposed a median price of KES200 (US$2). 
 Procurers are willing to procure the PVR and make it available through their distribution 
networks and outlets. They are willing to purchase the PVR at a much higher cost than what 
consumers had proposed.  
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 There is potential for the private sector to play an active role in FP provision for the 
introduction of the PVR by serving customer segments based on their level of willingness to 
pay. Social marketing organizations and commercial players can ease the burden on public 
health expenditure while tapping into Kenya’s growing economy, bringing consumers who 
have varying levels of ability to pay for FP products and services.  
All key stakeholders (i.e., women, providers, and procurers in public, private nonprofit, and private 
commercial sectors) were interested and supportive of the one-year ring. All the individuals 
interviewed were willing to pay for the long-acting ring at higher costs than the PVR. The median 
price for the one-year ring varied across the sectors—KES100 (US$1) in the public sector, KES400 
(US$4) in the private nonprofit sector, and KES500 (US$5) in the private commercial sector. The 
study determines the ability of public sector consumers to afford FP products and the potential for 
serving them via private sector mechanisms. 
In terms of utilization, the results generated will inform and guide the next steps about product 
introduction. Specifically, the findings of this study will be integrated with results from a market 
segmentation exercise conducted earlier to develop a pricing model for the PVR. The price will reflect 
not only the cost of goods sold (COGS) and costs of product introduction (e.g., training, educational 
material, marketing and branding, demand creation), but also the benefits to the health system (e.g., 
limited need for infrastructure and equipment, potential for multiple service outlets and health 
cadres). The results will also be useful to refine PVR market segmentation and tailor specific 





















According to the Kenya Demographic and Health Survey (KDHS) 2014, Kenya’s total fertility rate (TFR) is 
3.9 births per woman (3.1 urban and 4.5 rural). It is important to point out that the TFR has declined from 
8.1 births per woman in the mid-1970s to the current level of 3.9 births. The contraceptive prevalence 
rate (CPR) is usually defined as the percentage of currently married women using any contraceptive 
method. Slightly more than half of currently married women (58%) are using some method of 
contraception. Among currently married women, modern methods of contraception are more commonly 
used (53%) than traditional methods (5%). Of the modern methods, injectables are the most widely used 
(26%), followed by implants (10%) and the pill (8%). The calendar rhythm method is the most popular 
traditional method used (4%). 
Contraceptive prevalence increases dramatically with education. Near one-fifth (18%) of currently married 
women with no education use a method, while more than half of women with at least some primary-
school level of education use contraception. Women with three to four children are the most likely to use 
contraception (66%). Currently married women in the Central region have the highest CPR (73%), followed 
by women in the Eastern region (70%). Contraceptive use is lowest in the North Eastern region (3%). 
Table 1 provides information on family planning (FP) services (including sterilization) and how frequently 
these are offered, by facility type and managing authority (Kenya Service Provision Assessment [KSPA] 
2010).  
 
TABLE 1    Background characteristics 
 Modern FP 
Method 
Offered (%) 




Method Offered  
(%) 
Male or Female 
Sterilization  
Offered (%) 





Type of Facilities 
Hospital 85 75 91 67 46 51 
Health center 83 64 86 33 20 80 
Maternity 88 63 88 47 31 17 
Clinic 80 44 81 18 3 203 
Dispensary 89 59 94 22 2 340 
Managing Authority 
Government 96 64 97 33 11 344 
NGO 89 36 89 24 7 22 
Private 
(for profit) 
84 46 84 21 7 236 
Faith-based 
organization 
44 58 69 12 3 88 
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Despite the progress made in reducing fertility and increasing the contraception use prevalence rate, 
many women still experience a high unmet need for contraception. Part of the challenge in addressing 
current levels of unmet need is the limited use of contraception by women during the first 12 months 
postpartum, and the high discontinuation rates with about half of all users abandoning their methods 
6 months after adoption. New methods are needed that offer greater ease of use, are women-initiated, 
and do not require significant health infrastructure or medical provider involvement for service 
delivery. One such method is the Progesterone Vaginal Ring (PVR), a user-initiated, reversible 
contraceptive that, according to clinical trial data, is safe and effective for breastfeeding women.  
The Progesterone Vaginal Ring (PVR) is designed exclusively for addressing the postpartum family 
planning needs of breastfeeding women. While the PVR is already being used by women in nine 
countries in Latin America, women in sub-Saharan Africa, where breastfeeding is almost universal, 
have no access to this technology. To expand access in this region, the Population Council, with 
funding from the Bill & Melinda Gates Foundation (BMGF) and the United States Agency for 
International Development (USAID), conducted various pre-introductory activities in sub-Saharan Africa 
where women practice prolonged lactation and also have a high unmet need for postpartum family 
planning of up to 65% in many countries (Sonalkar et al. 2013). The assessment of “Willingness to 
Pay” (WTP) for the PVR was conducted to understand the economic factors that may determine its 
uptake and use. In the case of contraceptives, WTP informs about the value that people attach to the 
benefits of various contraceptives, especially their willingness and intention to purchase them at 
various assigned hypothetical prices.  
Ever-increasing changes in the funding landscape have prompted governments to explore “total 
market” solutions. The Total Market Approach (TMA) identifies specific roles for the public and private 
sectors in meeting the FP needs of the population. Specifically, it focuses on ensuring that free or 
subsidized contraceptives are available to the needy and poor, and social marketing channels and 
other private commercial sales of contraceptives cater to those who are able to pay. This approach 
can help ensure equity and sustainability of products and services over time and also manage funding 
shortfalls. Using TMA as a guiding design principle, this study provides new knowledge on the 
maximum amount of money that consumers are willing to pay for the PVR and a related ring, the one-




COUNTRY ECONOMIC CONTEXT 
According to the Kenya National Bureau of Statistics (KNBS 2015), Kenya’s economic growth was 
4.9% in the first quarter of 2015 compared with 4.7% in the same period in 2014. Categorized as a 
lower-middle-income country, with a population of close to 45 million people, Kenya is among the 
promising emerging economies in East Africa. The business environment has significantly improved in 
Kenya in recent years with investments in infrastructure, agriculture, manufacturing, and other 
industries. The construction of a new railway line, initially to run from Mombasa to Nairobi, is 




poverty reduction, the government is focusing on reducing the cost of doing business and encouraging 
private sector innovation and entrepreneurship as well as business expansion. 
The per capita household final consumption expenditure in Kenya (the market value of all goods and 
services, including durable products such as cars, washing machines, and home computers purchased 
by households) has been on an upward trend since 2014, reaching US$517,1 while the gross national 
income per capita has risen steadily from US$1,040 in 2011 to US$1,290 (current US$). In 2013, 
private health expenditure (% of GDP), which includes direct household (out-of-pocket) spending, 
private insurance, and charitable donations by private corporations, was 2.6, staying the same since 
2011. Public health expenditure2 (as % of GDP) was 1.9 in 2013 and has remained close to this level 
since 2011. Total health expenditure3 (% of GDP) has risen slightly from 4.3 in 2011 to 4.5 in 2013. 
Kenya’s Gross Domestic Product (GDP) is estimated at US$70 billion (2015 estimate) with an 







The average annual Consumer Price Index (CPI) increased from 140.1 in 2013 to 149.7 in 2014. 
This resulted in a modest increase in the rate of inflation and attributed to increases in the cost of 
several food and nonfood items, which outweighed notable falls in the cost of electricity and 
petroleum products including petrol, diesel, and kerosene. The inflation rate maintained its single-
digit level, rising from 5.7% in 2013 to 6.9% in 2014.4 With its competitive manufacturing sector 
driving new job creation and exports, Kenya is poised for successful economic growth. 
COUNTRY FAMILY PLANNING FINANCING CONTEXT  
 
In Kenya, the public and private sectors (including households) are the primary sources of 
reproductive health (RH) financing.5 Funding shortages have encouraged exploration of innovative 
financing models and coordinated action from the private sector, including social marketing 
organizations. The role of the private sector is largely underutilized and the public sector continues 
to take on a dominant role in providing FP products and services. The major sources of modern 
                                                                        
 
1  Data reported in constant 2005 US dollars. Sources: World Bank national accounts data and OECD National Accounts data files. 
2  Public health expenditure consists of recurrent and capital spending from government (central and local) budgets, external 
borrowings and grants (including donations from international agencies and nongovernmental organizations), and social (or 
compulsory) health insurance funds. 
3  Total health expenditure is the sum of public and private health expenditure. It covers the provision of health services (preventive and 
curative), family planning activities, nutrition activities, and emergency aid designated for health, but does not include provision of 
water and sanitation. 
4  Current World Bank data (2015). 
5  Republic of Kenya (2011), Kenya National Health Accounts 2009/10. 
TABLE 2   Cost of living snapshot in Nairobi, Kenya 
Commodity Quantity Average Price (US$) 
Milk 1 gallon 3.4 
Bread 1 pound 0.5 
Eggs 1 dozen 1.4 
Onion 1 pound 0.4 
Beef 1 pound 2.1 
Gasoline 1 gallon 1.7 
Source: www.numbeo.com. 
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contraceptives for women are public health facilities (57%) and private health facilities (a 
substantial 36%). Other sources, such as mobile clinics, community-based distribution, and shops, 
comprise the remaining six percent (KNBS and ICF Macro 2010). Kenya’s FP market provides a 
variety of methods—hormonal, intrauterine devices (IUDs), surgical, barrier, lactational 
amenorrhea method (LAM), and fertility awareness (DRH and MOPHS 2010). Injectables, priced 
slightly less than US$1 per unit, are clearly the most popular. Among women who pay for their 
method, median cost is highest for surgical contraception, at about US$30. Available methods for 
postpartum women include LAM, IUCDs, sterilization, progestogen-only pills, injectables, and 
condoms, with injectables again being the most common (Gebreselassie, Rutstein, and Mishra 
2008; DRH and MOPHS 2010). 
 
In collaboration with development partners, the Ministry of Public Health and Sanitation (MOPHS) 
and the Ministry of Medical Services (MOMS) developed a Costed Implementation Plan (CIP) for FP 
following the guidelines in the National Reproductive Health Policy 2007 and the National RH 
Strategy 2009-2015. Interventions and activities to promote CPR that will increase as per 
FP20206 commitments are outlined in CIP. The key thematic areas identified in CIP are human 
resources, integration, commodity security, youth, advocacy, and demand creation. Other notable 
interventions include the Tupange project,7 funded by BMGF under its Urban Health Reproductive 
Initiative (URHI), which aims to increase CPR by 20 percentage points in selected project areas in 
Kakamega, Kisumu, Machakos, Mombasa, and Nairobi. Expanding the role of the private sector 
will not only accelerate Kenya’s progress toward the FP2020 goals but also enable the Kenyan 
government to redirect investment on other health priorities. 
STUDY OBJECTIVES 
The overall goal of the study was to generate evidence on the potential market dynamics that will inform 
the introduction of a new contraceptive method in sub-Saharan Africa. The specific objectives of the study 
were to: 
1) Obtain reliable estimate of consumers’ demand for the PVR in Kenya by studying the effect of 
price on demand;   
2) Assess the “Willingness to Provide” by family planning providers and “Willingness to Procure” by 
procurers; 
3) Facilitate evidence-based pricing for the PVR in the three sectors of interest—public, private 
nonprofit, and private commercial; and 
4) Explore respondents’ WTP for future vaginal rings (including long-acting, reversible options for 
nonbreastfeeding women) to assess potential demand and design access strategies. 
  
                                                                        
 
6  FP2020: http://www.familyplanning2020.org/. 





STUDY DESIGN AND METHODOLOGY 
A cross-sectional study was conducted in three countries in sub-Saharan Africa (Kenya, Nigeria, and 
Senegal). The study used a multidimensional and multisectoral approach, which examined willingness to 
pay for the PVR in the three countries. These approaches included: 
Stakeholder-driven approach to WTP: We identified three actors in the PVR WTP assessment landscape—
potential consumers, providers, and procurers. We explored the three dimensions of WTP—WT Pay, WT 
Provide, and WT Procure—by incorporating the voices of these three stakeholders in the data collection 
tools.  
Sector-driven approach to WTP: Using the guiding principles of improved access, efficient use of public 
resources, and increased equity, we explored a potential total market model for the PVR by exploring the 
views and expectations of different sectors that serve FP customers—the public, private nonprofit, and 
private commercial sectors.  
Table 3 summarizes the survey tools and methodology used in this WTP study including specific survey 
instruments that were designed for target respondents. 
The WTP study was conducted in Nairobi County because the county has the highest concentration of 
urban, educated women from more wealthy households. Since FP is provided free of charge in Kenya, it is 
important to know if there is a segment of the population that will be able to pay for the ring—either 
subsidized or full price—especially since there is a deliberate global effort to have all economies move to 
a total market approach. In addition, Nairobi also has the highest concentration of health care facilities 
and agencies involved in procuring FP commodities. Study populations were:  
a) Numbering close to 400 women (397) aged 18–49 years seeking family planning services at 
selected health facilities in Nairobi County. The total number of participants was distributed as 
follows: public (278); private nonprofit (14) and private commercial (105). Questions on 
consumer characteristics were included to gauge household expenses, family income, and 
discretionary expenses, which will determine “ability to pay” for the PVR. Questionnaires were 
designed using the standard format for the Contingent Valuation Methodology (CVM), which has 
three sections: (1) socioeconomic background; (2) knowledge and need for postpartum FP; and 
(3) WTP for the PVR.  
TABLE 3   Study design, methodology, and scope 
Stakeholder Survey Instrument Target Respondents 
Consumers 
a) WT Pay Survey 
b) Price-Tracking Survey 
a) Potential consumers (women aged 18–49 years old)  
b) Pharmacists; facilities in charge at social marketing 
outlets; and public FP clinics 
Providers WT Provide Survey 
FP service providers and members of professional 
associations, such as pharmacists, ob/gyns, midwives, 
nurses, other providers 
Procurers WT Procure Survey 
MOH, USAID Mission, UNFPA, MSI/Kenya, and large 
pharma distributors 
8 
b) Family planning service providers aged 18 years and above in selected health facilities. We 
interviewed 10 providers from the initial pilot sites and 50 other providers drawn from health 
facilities that were not part of the PVR pilot study. The providers were asked qualitative questions 
to gauge their willingness to provide the PVR as part of the existing FP method mix in their health 
facilities. 
In addition, they were asked to estimate the maximum amount that should be charged (if any) for 
providing the PVR. Respondents included randomly selected FP providers such as gynecologists, 
nurses and midwives, clinical officers, and pharmacists.  
c) In charge of selected health facilities. A total of 50 health facilities were assessed in the price-
tracking survey. Out of this total, 17 were from the public sector, 6 were from the private 
nonprofit sector, and 27 were from the private commercial sector. 
d) Representatives of government, social marketing, and donor agencies involved in procuring FP 
commodities. Out of 23 procurers who were interviewed, 3 were from the public sector; 8 were 
from the private nonprofit sector, and 12 were from private commercial sector.  
e) Procurers were asked to provide the price list of procured FP commodities and their assessment 
of a reasonable price estimate for procuring the PVR, to assess their “willingness to procure” it. 
After being provided with a detailed description of the PVR, procurers were asked their willingness 
to buy the PVR for a modest starter price and then to state their maximum willingness to pay to 
procure the PVR.  
In conducting the survey, the following procedures were followed:  
Since the PVR is a new product, respondents were shown a product sample and provided a full 
description, including the ring’s use and benefits. Examples were given to draw connections with 
comparable products, such as progestogen-only pills.  
To reduce bias, user interest was ascertained by providing an option to rate interest in the PVR before 
starting the survey. Uninterested respondents were not interviewed.  
Different WTP price references for the PVR were used depending on the type of sector where clients who 
were interviewed had gone to seek services. For instance, in the public sector, data was captured on the 
maximum service fee that the potential user was willing to pay for the PVR.  
In the private nonprofit sector, the WTP measure was the subsidized price for the PVR that the potential 
user was willing to pay. In the private commercial sector, the WTP measure referred to the maximum 
selling price the consumer was willing to pay.  
We used the current price of a three-month supply of Progestogen-only pills before determining the 
hypothetical price ranges we tested. Questions for respondents started with a modest price assumption 
for the PVR of KES90 (US$0.90) in the public sector; KES120 (US$1.20) in the private nonprofit sector, 





We ended the interview with two open-ended questions: (1) We asked the maximum price the respondent 
was willing to pay for the PVR independent of the previously mentioned prices; (2) We sought to know the 
possible action the respondent would take if the price were found to be too high. See Figure 1 for the 
sequence of questions asked, which were adapted from Foreit and Foreit (2001). 
DATA COLLECTION 
The Ethics and Research Committee (ERC) of Kenyatta National Hospital, University of Nairobi granted 
ethical clearance for the study. The National Commission for Science, Technology, and Innovation 
(NACOSTI) granted the research permit for the study. 
The data collected were manually entered into EPI DATA. A direct estimation model for calculating the 
demand curve as described in the WTP study manual was used (Foreit and Foreit 2001). All responses 
with a maximum WTP price were checked for internal consistency. (The maximum price stated had to 
be equal to or higher than the highest price accepted. Demand curves were derived from frequency 
distributions of the maximum WTP price.) The WTP technique described here includes the assumption 
that only the price varies and all other factors remain constant.  
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Results 
The WTP study was structured into four components: namely a price-tracking survey, interviews with 
potential consumers, and a survey among providers and procurers. Table 4 shows the sample sizes 
achieved by study components and sectors surveyed.  
PRICE-TRACKING SURVEY 
As shown in Table 4, 17 public sector facilities, 6 private nonprofit facilities, and 27 private commercial 
facilities participated in the survey. Health providers in charge of facilities (doctors, nurses, clinical 
officers), or pharmacists or other pharmacy staff in the case of chemists, were asked to name 
contraceptives available in their respective facilities and the corresponding price(s) for each category of 
contraceptives on the day of the interview.  
Contraceptives that were in stock most of the time were injectables (Depo-Provera or DMPA), implants 
(Jadelle), pills (Progestogen-only pills or Microlut, combined oral contraceptives or Femiplan), and male 
condoms. Others were emergency contraceptive pills and copper intrauterine devices (IUDs). 
Respondents in public health facilities pointed out that breastfeeding women in the postpartum period 
were facing a challenge in accessing a suitable FP method due to frequent and prolonged stock-out of 
Microlut.  
The majority of respondents in public sector facilities indicated that they dispensed or issued 
contraceptives to their clients free of charge as per government policy.8 However, respondents in the 
private nonprofit and private commercial sectors said that they levied a fee for various types of 
contraceptives even if the source of the contraceptives was the Kenya Medical Supplies Agency (KEMSA), 
which is a government institution under the Ministry of Health. 
As shown in Table 5, the median price of injectables (or DMPA) was KES100 (US$1) across the private 
nonprofit and private commercial sectors. The median price for pills was much lower in the private 
nonprofit sector at KES20 (US$0.2). The cost of implants was much higher in the private commercial 
sector at KES1,000 (US$10). Most of the respondents acknowledged that the price of contraceptives 
shown in Table 5 included a markup to cover labor costs and other recurrent costs at the facility or within 
                                                                        
 
8 Ministry of Health, Republic of Kenya (2000): “Family Planning and Reproductive Health Commodities in Kenya Background Information for 
Policymakers.” 
TABLE 4      Sample sizes achieved by study component and sector 






 n % n % n %   
Price-Tracking 17 34 6 12 27 54 50 100 
Consumers 278 70 14 4 105 26 397 100 
Providers 17 27 6 9 41 64 64 100 
Procurers 3 13 8 35 12 52 23 100 




the program or management chain that was responsible for running the facility or chemist(s). Most of the 
respondents were not aware of the exact figure for the markup. They indicated that the business owners 
knew the percentage of markup or taxation. This finding is similar in other countries (Nigeria and Senegal) 
as well.  
Frequency of Fee Structure Changes 
Regarding the frequency of changes to the fee structure for contraceptive methods, a significant 
proportion of respondents in the private nonprofit and private commercial sectors said that their fee 
structure does not change very often and remains relatively stable for extended periods of time. A few of 
them said that the fees did change on a weekly basis. Others said that the fees could even change on a 
daily basis. Four of the respondents said that they changed the fees on a quarterly basis. Three 
respondents said that they changed the fees semi-annually. The rest of the respondents said that the 
change in fees levied was dependent on the manufacturers’ conditions, including the going price as well 
as the supply and demand for pharmaceuticals in general and for contraceptives in particular. 
Frequency of Contraceptive Stock Delivery 
The majority of respondents said that they received contraceptive stocks in less than a month. Some 
mentioned quarterly supply, especially those who receive stocks directly from government stores (i.e., the 
Kenya Medical Supplies Agency). A smaller proportion of respondents mentioned that they received their 
stocks semi-annually or annually. 
General Comments and Observations of Respondents 
At the end of the interview, the interviewer provided an opportunity for respondents to ask questions or 
offer observations regarding the interview. The majority of respondents asked whether staff in the private 
sector would be considered for training on the PVR. Others wanted to know whether the PVR would 
replace Microlut, which has not been in stock for quite some time. Respondents raised the issue of 
hygiene and potential infection if proper hygiene measures are not taken with the PVR. Some 
respondents asked whether men would be allowed to purchase the PVR for their partners. Others pointed 
out that FP commodities are free of charge in government health facilities and asked whether the PVR will 
also be free of charge in those facilities. Some observed that the PVR would expand method mix, 
especially for women in the postpartum period.  
TABLE 5      Median prices of commonly available contraceptives by sector in Kenya 
 Brand Median Price (KES) Median Price (USD) 
Private Nonprofit Sector 
  Injectables Depo-Provera 100 1 
  Implants Jadelle 400 4 
  Pills Microlut  20 0.2 
Private Commercial Sector 
  Injectables Depo-Provera 100 1 
  Implants Jadelle 1,000 10 




Demographic Characteristics of Study Participants by Sector 
As shown in Table 6, the majority of the clients who were interviewed in the public sector (41%) and 
private nonprofit sector (43%) were between 20 and 24 years of age. The majority of those interviewed 
from the private sector were between 25 and 29 years of age. A majority (46%) of those interviewed in 
the public sector had secondary education, 43% of those interviewed in the private nonprofit sector had 
both primary and college/graduate education, while 57% of those interviewed from the private 
commercial sector had college/graduate education. Most of the clients interviewed in the public (90%) 
and private commercial (83%) sectors were married, compared to 64% in the private nonprofit sector.  




Private Nonprofit Sector 
(n=14) 
Private Commercial Sector 
(n=105) 
 % % % 
Age 
  15–19 4 0 1 
  20–24 41 43 26 
  25–29 35 21 43 
  30–34 14 7 18 
  >35 7 29 12 
Highest Level of Education 
  None, never attended 0 0 2 
  Primary 37 43 14 
  Secondary 46 36 27 
  College/graduate 17 43 57 
Marital Status 
  Married 90 64 83 
  Not currently married 10 36 17 
Employment Status 
  Housework/not working 45 29 27 
  Business 20 29 22 
  Government  1 0 11 
  Manual/temporary work 10 0 6 
  Student 2 21 8 
  Other 22 21 27 
Spouse Employment Status 
  Business 28 0 33 
  Government  10 22 27 
  Manual/temporary work 30 34 11 





Overall, the spouses of the clients who were interviewed were twice as likely to be engaged in business or 
in manual/temporary work compared to the women themselves. None of the respondents and partners 
who were interviewed at the private nonprofit health facilities cited the government as the institution or 
place where they are employed. 
These findings contrast with those obtained from respondents who sought services from private for-profit 
health facilities, where 27% of spouses cited the government as a place where they are employed. In 
summary, respondents who were interviewed in the private commercial sector presented a higher 
socioeconomic profile.   
Socioeconomic Characteristics of Study Participants by Sector 
The socioeconomic characteristics of study participants addressed in this section are: a) number of 
children; b) family planning use; c) monthly FP expenditure; and d) household items (Table 7a). Nearly 
half of the women (48%) who were interviewed in the public sector had given birth to one child. 
Nearly 55% of those interviewed in the private nonprofit sector had at least 3 children, while 50% of those 
interviewed from the private commercial sector had 2 children. The majority of the women were current 
users of FP services. As expected, most of those who paid for FP services were interviewed at the private 
commercial sector facilities with the majority spending between KES 50–199 (US$0.5–$2) per month. 








 % % % 
Number of Children  
  1 48 27 28 
  2 34 18 50 
  3 14 55 14 
  4+ 5 0 8 
Family Planning Use 
  Not using and does not intend to use in the future 4 7 6 
  Yes, currently using  82 71 79 
  Not currently using, but intends to use in the future 14 14 15 
Monthly FP Expense (KES) 
  <50 29 0 1 
  50–199 50 33 58 
  200–499 4 33 10 
  500–999 7 17 16 
  >1,000 11 17 15 
Household Items 
  Television 80 86 97 
  Refrigerator 13 14 57 
  Vehicle 7 14 26 
  Mobile 99 93 100 
  Radio 82 86 87 
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A much higher proportion of women (58%) who were interviewed at the private sector commercial 
facilities spent between KES50–199 (US$0.5–$2) per month on FP services compared to those who 
sought services in the public and nonprofit sectors.  
The majority of clients interviewed at the private commercial sector facilities possessed most of the 
household items, such as televisions, compared to those who sought services from the public and 
nonprofit health facilities. Those clients who sought services from the public facilities had the least 
amount of household items, followed by the private nonprofit health facilities. No differences were noted 
in mobile phone ownership across the three sectors, indicating that the level of discretionary spending on 
mobile phone use may be similar. This also suggests that mobile services may be useful in PVR client 
counseling or follow-up.  
Visits to Hair Salon, Monthly Expenditure, and Income Level 
The average monthly expenditure for the majority of clients (97%) who sought services from the public 
sector was less than KES50,000 (US$500). Approximately 12% of the clients who sought services from 
the private commercial sectors spent over KES100,000 (US$1,000) per month. None of the clients spent 
more than KES100,000 (US$1,000) to seek services in the public sector. Approximately 84% of the 
clients who sought services from the public sector had a monthly income that ranged from KES10,000–
100,000, whereas 12% of the clients who sought services from the private or commercial sector facilities 
spent over KES100,000 (US $1,000). None of the clients interviewed while seeking services from the 
private nonprofit sector had a monthly total income of over KES100,000 (US $1,000). (Table 7b.) These 
data confirm that respondents from the private sector are economically more advantaged than those who 
were interviewed at public sector facilities. Furthermore, a comparison of the two sectors suggests that 
the public sector may be serving some who could potentially pay for services and should ideally be 
seeking services in the private sector. 
  








 % % % 
Salon Visits 
  Weekly 5 0 11 
  Monthly 65 79 64 
  Other 19 21 16 
  Do not know 11 0.0 9 
Monthly Expenditure (KES) 
  <50,000 97 84 69 
  50,000–100,000 3 8 19 
  >100,000 0 8 12 
Income Level (KES) 
  Low (<10,000) 13 27 3 
  Medium (10,000–100,000) 84 73 74 





Consumer Interest in Purchasing the PVR 
As shown in Table 8, potential consumers indicated that they would be interested in purchasing the PVR if 
it becomes available in the future.    
As shown in Table 8, out of the 397 respondents interviewed, 269 (68%) were willing to purchase the PVR 
if it were made available in future. The responses were similar across all sectors (public, private nonprofit, 
and private commercial). 
Reference Prices for Willingness to Pay (WTP) by Sector 
The reference WTP prices for the PVR by sector are shown in Table 9. 
WTP for the PVR 
Respondents were asked a series of questions regarding their willingness to pay for the PVR at the starter 
price, at a 10% increment, and at a 20% increment. The responses to the respective questions are 
outlined in Table 10.  
TABLE 8     Consumer interest in purchasing the PVR by sector 
Variable 







 n % n % n % n % 
Yes, I would be interested in 
purchasing the PVR 
192 69 9 64 68 65 269 68 
No, I would not be interested 
in purchasing the PVR 
86 31 5 36 37 35 128 32 
Total 278 100 14 100 105 100 397 100 
 
TABLE 9      Reference WTP Prices for the PVR by Sector 
Provider Profile Public Sector (KES) 




Starter price 90 (US$0.90) 120 (US$1.20) 150 (US$1.50) 
Price after 10% increase 100 (US$1.00) 130 (US$1.30) 165 (US$1.65) 
Price after 20% increase 110 (US$1.10) 145 (US$1.45) 180 (US$1.80) 
Price after 5% decrease 85 (US$0.85) 115 (US$1.15) 145 (US$1.45) 
 






Private Commercial  
Sector (n=105) 
Total 
 n % n % n % n % 
Respondents interested 
in the PVR 192 69 9 64 69 66 270 68 
Starter price 164 85 9 100 68 98 241 89 
10% increment 147 77 9 100 57 83 213 79 
20% increment 86 45 5 56 52 75 143 53 
 
16 
As seen in Table 10, 68% were interested in the PVR with little difference across the sectors. The demand 
for the PVR at the starter price equaled 89%, with variations across the sectors. Most of those interviewed 
in the public sector (85%) were willing to pay at a starter price of KES90 (US$0.90) and all those 
interviewed in the private nonprofit sector were willing to pay at a starter price of KES120 (US$1.20). 
Approximately 98% of those who sought services from the private commercial sector were willing to pay 
KES150 (US$1.50) as a starter price.   
Furthermore, it is interesting to note that with price increases, although there is an expected decline in 
the proportion willing to pay the new price, there is also a clear pattern. At a 20% increment, respondents 
in the public sector are most sensitive to the price change, followed by the private nonprofit and private 
commercial sectors. This pattern confirms our belief that paying users of the PVR are likely to be in the 
private sector. 
WTP More for Women in Low-Resource Settings 
A significant proportion of respondents were willing to help women in low-resource settings access 
contraceptive services. For instance, 77% of clients (Table 11) indicated that they were willing to pay the 
maximum amount quoted, plus a 5% increase over the price if it can be used to fund contraceptive supply 
for women in low-resource settings. 
WTP Maximum Price for the PVR 
As shown in Table 12, 94% of clients were willing to pay less than KES500 (US$5) for the PVR. Of those 
respondents who were willing to pay less than KES500 (US$5), 98% sought services from the public 
sector and 100% from the private nonprofit sector. At least 6% of clients were willing to pay more than 
KES500 (US$5) for the PVR. 
TABLE 11      Respondents’ WTP more to fund contraceptive supply for women in low-resource settings 






 n % n % n % n % 
Yes, willing to pay 140 74 6 67 59 87 205 77 
No, not willing to 
pay 
42 22 3 33 8 12 53 20 
Do not know 8 4 0 0 1 1 9 3 
Total 190 100 9 100 68 100 267 100 
 
TABLE 12      Respondents WTP maximum price for the PVR 
Maximum 
Price (KES) 






 n % n % n % n % 
<500 188 98 9 100 57 83 254 94 
500–1,000 2 1 0 0 9 13 11 4 
1,000–1,500 0 0 0 0 3 4 3 1 
>1,500 1 1 0 0 0 0 1 1 





Reasons for Agreeing to Pay 
Those respondents who agreed to pay more, including a 5% increase, cited a number of reasons for doing 
so. Some said that the price was affordable and desired an FP method for use during the postpartum 
period. Others reported that an unintended pregnancy could lead to medical complications and higher 
expenses in the management of such complications. Hence paying for an FP method instead of 
anticipating complications related to pregnancy was the rationale. The respondents who were not willing 
to pay more, including a 5% increase over the price, believed that the price was too high and noted the 
fact that there were less expensive alternatives on the market. 
Suppose the Selling Price of the PVR Is Too High? 
A majority of the respondents said that they would look for affordable alternatives (52%) and go to places 
where the PVR is given free of charge (27%) if the selling price of the PVR turns out to be too high for 
them. Most of the respondents who cited affordability issues sought services from the private nonprofit 
sector followed by those who sought services from the public sector. 
Consumer Demand Curve for PVR by Sector  
In this section, two sets of consumer demand curves for the PVR are shown, namely the public and 
private commercial sectors. The demand curve for the private sector combines the clients who were seen 
in the private nonprofit and private commercial sectors. Combining views of clients from the private 
commercial sector and those of clients who were seen at the private nonprofit facilities was done due to 
the small sample size for the latter group. 
Public Sector Consumer Demand Curve 
As shown in Figure 2, a majority of respondents in the public sector were willing to pay up to KES500 
(US$5) for the PVR. The proportion of respondents who were willing to pay between KES500 (US$5) and 
KES2,100 (US$21) for the PVR drops dramatically at prices over KES500 and is almost negligible among 

































The steep drop in the demand for the PVR if the price exceeds KES500 (US$5) could be attributed to low 
income levels in the target community or among potential users. For instance, when public sector 
respondents were asked what form of transportation they used to travel to work, school or market, 
roughly 50% reported using public transportation, 41% said they walked, and 1% reported owning a 
vehicle. As noted earlier, the mean hair salon expense per visit for public sector respondents was 
KES660 (US$6.60). These respondents also made less visits to the salon compared to clients who sought 
FP services in the private sector. 
Private Sector Consumer Demand Curve  
As seen in Figure 3, the consumer demand curve for private sector respondents was less steep. For 
instance, a significant proportion of the clients were willing to pay for the PVR even if the price exceeded 
KES500 (US$5). 
The shape of the consumer demand curve for the private sector is consistent with the observation made 
earlier (see Table 7b) regarding visits to hair salons. The mean salon expense per visit for private sector 
respondent was KES1,160 (US $11.6) and private sector respondents made more weekly visits to salons 
compared to public sector respondents. 
In addition, about 70% of private sector clients were willing to pay for contraceptives, compared to only 
30% of the clients who sought services from the public sector health facilities. 
Reasons for WTP for the PVR 
Respondents cited many reasons for their willingness to pay for the PVR (Figure 4). For instance, 45% of 
the private sector respondents and 35% of the public sector respondents mentioned an “affordable 
price.” Other responses included: 
 Provider recommendation (public sector 11%, private sector 9%);  
 Wanting or liking the method (public sector 19%, private sector 18%);  
 Do not want unintended pregnancy (public sector 16%, private sector 23%); and  
 I want to help women get access to this FP method (public sector 51%, private sector 46%). 
 

































It is worth pointing out that except for in the case of affordability, where the proportion of respondents in 
the private sector was clearly greater than that in the public sector, the rest of the responses were more 
or less similar across sectors. The least cited reason for respondents’ willingness to pay for the PVR was a 
“provider recommendation,” which was only cited by 11% in the public sector and 9% in the private 
sector.  
WTP for a One-Year Contraceptive Vaginal Ring (CVR) for Nonbreastfeeding Women  
Respondents who participated in the WTP for the PVR were also asked if they would be interested in 
using a new type of method with different features, namely a long-acting reversible contraceptive vaginal 
ring (CVR) for nonbreastfeeding women. Since the nonbreastfeeding ring is a new product, respondents 
were provided with a full product description including its use and benefits, and the fact that it can be 
used for up to one year and is meant for nonbreastfeeding women. Examples were given to draw 
connections with comparable products such as implants. 
To reduce bias, user interest was ascertained by providing an option to rate interest in the one-year CVR 
before proceeding with the interview. Thus, we specifically asked if they would be interested in using a 
new type of contraceptive method that is long-acting and reversible for nonbreastfeeding women. 
Uninterested respondents were not interviewed.  
Different WTP price references for the long-acting ring for nonbreastfeeding women were used depending 
on the type of sector where clients who were interviewed had gone to seek services. The current price of 
providing long-acting and reversible FP methods such as implants in the public, private nonprofit, and 
private commercial sectors was used in estimating the potential market price for the long-acting ring for 
nonbreastfeeding women. We ended the interview by asking the maximum price that the participant was 
willing to pay for the one-year CVR independent of the previously mentioned prices.  
  
 






























The responses from clients with regard to their interest in using the one-year CVR are outlined in  
Table 13. 
Most of the respondents (66%) in the public sector reported being interested in the one-year CVR. 
Respondents who sought services in the private nonprofit sector (85%) were most likely to agree to use 
the one-year CVR compared to 66% in the public sector and 62% in the private commercial sector. 
Reference Prices for WTP for the One-Year CVR 
The reference WTP prices for the one-year CVR are shown in Table 14. 
WTP for the One-Year CVR 
Respondents who had expressed interest in the one-year CVR were asked a series of questions to gauge 
their interest and willingness to pay the starter price, at a 10% increment, and at a 20% increment. The 
responses to the respective questions are outlined in Table 15.  
 
  









 n % n % n % n % 
Yes, interested 177 66 11 85 61 62 249 66 
No, not interested 91 34 2 15 37 38 130 34 
Total 268 100 13 100 98 100 379 100 
 
TABLE 14      Reference WTP Prices for the One-Year CVR  





Starter price 640 (US$6.40) 730 (US$7.30) 915 (US$9.15) 
Price after 10% increase 705 (US$7.05) 800 (US$8.00) 1,005 (US$10.05) 
Price after 20% increase 770 (US$7.70) 880 (US$8.80) 1,100 (US$11.00) 
Price after 5% decrease 610 (US$6.10) 695 (US$6.95) 870 (US$8.70) 
 









 n % n % n % n % 
Respondents interested 
in the one-year CVR 
177 66 11 85 61 62 249 66 
Starter price 89 50 7 64 43 71 139 56 
10% increment 56 63 3 43 33 75 92 66 





A significant proportion of respondents were willing to pay for the one-year CVR even at higher prices.  A 
majority of clients interviewed in the private commercial sector were willing to pay for the one-year CVR 
compared with those interviewed in the public and private nonprofit sectors. Public (50%), private 
nonprofit (64%), and private commercial sectors (71%) expressed their willingness to pay for the one-year 
CVR at the starter price. 
WTP Maximum Price for the One-Year CVR 
The responses on the maximum amount of money respondents would be willing to pay for the one-year 
CVR are shown in Table 16.  
About half (48%) of the respondents were willing to pay less than KES500 (US$5). The clients interviewed 
in public sector were the majority in this category (55%), compared to private commercial respondents 
where 25% agreed to pay less than KES500 (US $5). 
WTP Maximum Price Plus a 5% Increase 
A significant proportion of respondents were willing to help women in low-resource settings access the 
one-year CVR. For instance, 66% of women were willing to pay the maximum price plus a 5% increase 
over the maximum price if it can help widen FP access to women in low-resource settings (Table 17). 
About 77% of the respondents who were willing to pay the maximum price plus a 5% increment were in 
the private commercial sector. 
 
  
TABLE 16      Respondents WTP maximum price for one-year CVR 






 n % n % n % n % 
<500 97 55 6 55 15 25 118 48 
500–1,000 74 42 4 36 18 13 96 39 
1,000–1,500 1 1 1 9 11 18 13 5 
>1,500 3 2 0 0 16 27 19 8 
Total 175 100 11 100 60 100 246 100 
 









 n % n % n % n % 
Yes, willing to pay 106 63 6 55 44 77 156 66 
No, not willing to pay 55 33 5 45 11 19 71 30 
Do not know 7 4 0 0 2 4 9 4 
Total 168 100 11 100 57 100 236 100 
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Consumer Demand Curve for One-Year CVR 
In this section, two sets of consumer demand curves for the one-year CVR are shown, namely the public 
and private commercial sectors. The demand curve for the private sector combines the clients who were 
seen at the private nonprofit and private commercial facilities due to the small sample size for the latter 
group. 
Public Sector Consumer Demand Curve  
As shown in Figure 5, approximately 50% of the respondents in the public sector were willing to pay 
KES700 (US$7) for the one-year CVR. The WTP drops off substantially and tapers to less than 10% at 
prices over KES1,200, although there were a few potential clients who were willing to pay up to 
KES3,000 (US$30).  
  
Private Sector Consumer Demand Curve 
Compared to the demand curve in the public sector, the slope of the private sector demand curve is more 
gradual. As shown in Figure 6, approximately 50% of the respondents in the private sector were willing to 
pay KES1,250 (US$12.5) for the one-year ring, with a significant proportion (23%) willing to pay 
KES2,000. A few of the potential clients suggested they would pay up to KES4,000 (US$40).  
As seen in Figures 5 and 6, private sector clients were willing to pay a higher price for the one-year ring 
compared to public sector clients. 
  
 


































Sixty-four (64) providers were interviewed (17 from the public sector, 6 from the nonprofit private sector, 
and 41 from the private commercial sector). Sixty-two (62) of the providers had a college/university level 
of education, while two (2) had a secondary level of education. It should also be noted that the most 
popular methods on the market among clients are injectables, implants, and pills.  
Inclusion of the PVR into Available Contraception Options 
Research assistants were required to show a sample of the PVR to respondents as well as give them a 
brief description of the product including what it is and how it works. After providing a description of the 
product, respondents were then asked if they would support the inclusion of the PVR in the available FP 
options. Out of the 64 providers, nearly all of them (98%) said they would support the inclusion of the 
PVR. Only one respondent (2%) answered otherwise.  
In a related question, providers were requested to mention the most important reason for liking the PVR. 
Most of them cited “easy to use” (60%).  
Willingness to Provide the PVR to Clients If It Becomes Available  
Providers were asked whether they would be willing to provide the product to their clients if it becomes 
available. In response to this question, all 64 providers (100%) answered in the affirmative. Providers 
also gave an opinion on whether their clients would like the PVR. About 75% of providers suggested that 
their clients would like the product. Close to 10% indicated that their clients would not like the product, 
and the remaining 15% indicated that they did not know.   
  
 

































Providers’ Opinion Regarding Price for the PVR 
Providers were asked to give an opinion on what they thought was an appropriate price for the PVR. Table 
18 shows the smallest and the highest amount of money suggested by providers in each sector with the 
corresponding interquartile range, mean, and median amount.   
The median price suggested for the PVR was KES100 (US$1) in both the public and private nonprofit 
sectors. Compared to the public sector, mean and interquartile range was much higher in the private 
nonprofit sector. The median price for the PVR in the private commercial sector was KES200 (US$2) with 
a much larger interquartile range and mean compared to the public and private nonprofit sectors. Some 
of the providers suggested that an appropriate price for the PVR would be KES8,000 (US$80).  
Assessing Health Providers’ Interest in the One-Year CVR 
Providers were asked whether they would be interested in the one-year CVR. Out of the 64 providers 
interviewed, 59 of them (93%) responded in the affirmative. Only four (6%) were not interested. In a 
related question, providers were requested to mention the most important reason for liking the one-year 
CVR. Most of them cited the following reasons: long-acting (73%), used for nonbreastfeeding women (2%), 
and other (25%). (Data not shown.)  
Willingness to Provide the One-Year CVR If It Becomes Available  
All 59 providers (100%) said that they were willing to provide the one-year CVR to their clients if it 
becomes available. Out of the 59 providers, 86% said that their clients would like the one-year CVR, 2% 
said that their clients would not like it, and 12% said that they did not know. (Data not shown.) 
Providers’ Opinion Regarding Price for the One-Year CVR 
Providers were asked to give an opinion on what they thought was an appropriate price for the long-acting 
ring for nonbreastfeeding women. Table 19 shows the smallest and the highest amount of money suggested 
by providers in each sector with the corresponding interquartile range, mean, and median amount.   
TABLE 18    Providers’ opinion on appropriate price for the PVR by sector 
Sector n 
 Smallest  Amount 
(KES) 




Mean  (KES) Median (KES) 
Public  16 50 (US$0.5) 100 (US$1) 50 (US$0.5) 78 (US$0.78) 100 (US$1) 
Donors 6 50 (US$0.5) 3,000 (US$30) 150 (US$1.5) 583 (US$5.83) 100 (US$1) 
Private nonprofit 38 0 (US$0) 8,000 (US$80) 400 (US$4) 697 (US$6.97) 200 (US$2) 
Private commercial  60 0 (US$0) 8,000 (US$80) 200 (US$2) 521 (US$5.21) 100 (US$1) 
    
TABLE 19    Providers’ opinion on appropriate price for the one-year CVR by sector 
Sector n 
 Smallest  Amount 
(KES) 







Public  16 20 (US$0.2) 500 (US$5) 150 (US$1.50) 176 (US$1.76) 100 (US$1) 
Donors 5 30 (US$0.3) 8500 (US$85) 1050 (US$10.50) 2076 (US$20.76) 400 (US$4) 
Private nonprofit 36 100 (US$1) 10,000 (US$100) 750 (US$7.5) 1,088 (US$10.88) 500 (US$5) 
Private commercial  57 20 (US$0.2) 10,000 (US$100) 300 (US$3) 918 (US$9.18) 300 (US$3) 




The median price for the one-year CVR was KES100 (US$1) in the public sector. The median price in the 
private nonprofit sector was KES500 (US$5) with a much larger interquartile range of KES750 (US$7.5) 
and mean of KES1,088 (US$10.88) compared to the public sector. The median price for the one-year 
CVR in the private commercial sector was KES300 (US$3) with an interquartile range of KES300 (US$3) 
and mean of KES918 (US$9.18). Some of the providers in the private commercial sector suggested that 
an appropriate price for the one-year CVR would be KES10,000 (US $100).  
A comparison of the lowest and highest prices that providers were willing to pay for the PVR and one- year 
CVR is made in Figure 7.  
As can be seen, providers suggested much higher prices for the longer-lasting ring compared to the PVR. 
PROCURER SURVEY 
Twenty-three (23) procurers were interviewed—three from government, two represented donors, six from 
the private nonprofit sector, nine from the private commercial sector, and three others (Table 20).   
The private commercial sector constituted the largest group of procurers (39%). 
  
 
FIGURE 7  WTP (AS QUOTED BY PROVIDERS) FOR THE PVR AND ONE-YEAR CVR 
    
 
TABLE 20    Procurers consulted during the PVR WTP study 
Type Frequency  (n=23) Percentage 
Government 3 13 
Donor 2 9 
Private nonprofit 6 26 
Private commercial 9 39 
Other 3 13 
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Frequently Procured Contraceptive Methods 
The most frequently procured contraceptives mentioned by respondents were combined oral 
contraceptives (pills), injectables (DMPA), emergency contraceptive pills (Postinor-2), implants (Jadelle 
and Implanon), and IUDs. Other respondents said that they do obtain contraceptives from the Kenya 
Medical Supplies Agency (KEMSA) and then distribute or dispense to their clients.  
Process of Procuring Contraceptives  
Procurers were asked to describe the process of procuring contraceptives in their respective 
organizations. The various approaches followed in procuring contraceptives are described in Box 1.  
Setting of Procurement Prices for Contraceptives  
Procurers were given an opportunity to describe how procurement prices for contraceptives are set in 
their respective organizations. The process or procedures followed in setting procurement prices for 
contraceptives are outlined in Box 2. 
 
 
BOX 1 PROCESS OF PROCURING CONTRACEPTIVES 
 











BOX 2 PROCESS OF SETTING PROCUREMENT PRICES FOR CONTRACEPTIVES 
 










 Done by national government in conjunction with KEMSA 
 We usually call the suppliers and then they deliver  
 We always do open tendering  
 Procurement office at the head office does it for us 
 We do quantification and forecasting based on consumption data  
 We fill in the order form and then send it to the supplier 
 We procure from importers 
 We approach manufacturers directly  
 We work closely with UNFPA, USAID, and the government to arrange for procurement  
 Tenders are issued out, then whoever wins the tender supplies the contraceptives 
 Once our products are out of stock, we call the supplier and make the order  
 Most of our procuring process takes place through global partnerships 
 
 The government usually initiates the process of setting procurement prices 
 The source or type of distributor determines the price of the drugs/FP at the pharmacy 
 Procurement prices vary a lot and are set by the supplier or importer 
 Determining the price is done centrally using international mechanisms within the company, which sets the 
best access price 
 We negotiate for the cheapest prices directly from the manufacturers 
 Most of the time contraceptives are procured from outside Kenya and so procurement prices are set 
internationally depending on the strength of the dollar or some other currency 
 We usually go for competitive prices. For example, the price of implants has come down because of the global 
commitment to get more women access to effective FP methods.  
 Our company has already prescribed fixed prices for us. They recommend the prices we give. 
 There are different prices for suppliers and retailers. Supplier prices are done at the national level. 
 Other organizations negotiate with manufacturers so that the contraceptives can be purchased at the lowest 




 Frequency of Changes in Procurement Costs  
Procurers were asked to describe the frequency of changes in procurement costs for contraceptives. 
Different groups of procurers made the statements outlined in Box 3. 
 
Family Planning Commodity Prices, Taxation, and Markup 
Procurers were asked to confirm or acknowledge if pricing included taxes and markups. Their responses 
are outlined in Table 21. About half of the respondents did not know whether the price charged included 
a markup. A much bigger proportion (61%) of respondents said that the commodity prices did not include 
taxes.  
Quality Control Process for Procurement of New Contraceptives 
Procurers were asked to describe the quality-control process that their respective organizations must 
follow when procuring new contraceptives. Some of the examples that were offered by data collectors 
(during the discussion) to clarify the question included WHO PQ, EML, and SRA. The responses to this 
question are outlined in Table 22. 
  
 
BOX 3 FREQUENCY OF CHANGES IN PROCUREMENT COSTS 
 











TABLE 21    Procurers’ views on commodity pricing, taxes, markup, and levels involved 
Type n Percentage Estimated Proportion of Taxation (for Yes Response) 
Response (Taxation) 
Yes (pricing including 
taxation) 
9 39 16% (Value Added Tax); others said that taxes are included 
in the pricing but did not know the rate or percentage. 
No 14 61 N/A 
Response (Markup) 
Yes (pricing including 
markup) 
12 52 Ranges from 1.33% to 30% 
No 11 48 N/A 
 
 Procurement costs vary monthly and depend on agents, distributors, or suppliers. When the supplier 
increases the price, the chemists also increase the retail price. If they drop the price, the retail price also 
drops.  
 Depends on demand. Sometimes the prices change twice a year. 
 Procurement costs rarely change. Sometimes they change annually. Prices could either increase or decrease 
depending on demand and supply forces.  
 Usually increase due to additional annual taxation  
 We get most of the FP supplies from the Ministry of Health so we do not experience price changes 
 Changes in procurement costs depend on the raw materials, the cost to the government, and market prices 
 Price changes are dependent on what the manufacturer gives distributors or procurers  
 Price changes are not very common since we buy directly from a company (we try to keep it fixed) 
 Procurement costs hardly change. Maybe after every 5 years. 
 Procurement costs depend on the strength of the dollar and yen because most of the FP products are 
manufactured overseas and so it would be difficult to answer this question directly 
28 
The majority of respondents cited the quality-control process mandated by WHO and KEMSA as being the 
reference point to be followed in procuring new contraceptives. 
Assessing Procurers’ Interest in Purchasing the PVR  
Procurers were asked whether they would be willing to purchase the PVR if it becomes available. In 
response to this question, 19 out of the 23 procurers (83%) answered in the affirmative (Table 23). The 
four procurers who showed no interest in purchasing the PVR are not involved in FP commodities. The 








Procurers’ WTP Maximum Price for the PVR 
The responses on the maximum amount of money procurers would be willing to pay for the PVR are 
shown in Table 24.  
 
TABLE 22   Quality-control process followed to procure new contraceptives 
Type n Percentage 
Follow quality-control standards of WHO/MOH/KEMSA 11 48 
Organization has an internal quality-control department that assesses quality issues 3 13 
Purchase only products that are already registered in Kenya  5 22 
Organization manufactures commodities and has an internal mechanism for quality 
assurance and appropriate infrastructure to maintain recommended conditions.  
3 13 
Buy commodities only from reliable sources 1 4 
Total 23 100 
 
TABLE 23   Assessing procurers’ interest in purchasing the PVR 
Type Response Total 
 Interested Not Interested  
Government 3 0 3 
Donor 2 0 2 
Private nonprofit 6 0 6 
Private commercial 5 4 9 
Others 3 0 3 
Total 19 4 23 
 
TABLE 24     Procurers’ opinion on appropriate price for PVR by sector 
Sector n 
Smallest  Amount 
(KES) 




Mean  (KES) Median (KES) 
Public  2 200 (US$2) 255 (US$2.55) 55 (US$0.55) 227 (US$2.27) 227 (US$2.27) 
Donors 2 100 (US$1) 500 (US$5) 400 (US$4) 868 (US$8.68) 300 (US$3) 
Private nonprofit 5 0 (US$0) 850 (US$8.50) 100 (US$1) 270 (US$2.70) 200 (US$2) 
Private  commercial  5 90 (US$0.9) 3,000 (US$30) 950 (US$4) 697 (US$6.97) 200 (US$2) 
All providers 
(combined) 
16 0 (US$0) 3,000 (US$30) 400 (US$4) 465 (US$4.65) 200 (US$2) 




The mean price for the PVR ranged from KES227 (US$2.27) in the public sector to KES697 (US$6.97) in 
the private commercial sector. A comparison of the lowest and highest prices that procurers were willing 
to pay for the PVR by sector is made in Figure 8.  
Procurers in the private commercial sector were willing to pay the highest maximum price for the PVR.  
Assessing Procurers’ Interest in the One-Year CVR 
Procurers were asked whether they would be interested in the one-year CVR. Nearly all the procurers 
(95%) responded in the affirmative, and cited many reasons why they would be interested in the one- year 







The procurers also pointed out the following issues: information on method effectiveness and side effects 
should be shared widely; male involvement will be critical; emphasis needs to be made that the new method 
will not prevent HIV; myths need to be addressed about FP methods being inserted into the vagina. 
                                                                        
 
9 A complex medication regimen—daily reminders, schedules, dosage; one that taxes a patient’s adherence. 
 
FIGURE 8 PROCURERS’ WTP MAXIMUM PRICE BY SECTOR 
 
 
TABLE 25   Procurers’ interest in the one-year CVR 
Reason Frequency 
The method will provide an alternative to mothers (and address the pill burden9) 2 
If the method is in the country and it is effective, we will of course try it. 3 
If women and their partners are willing to use it, then it will widen the options available  3 
If there are no complications, then it is a good product 3 
We are open to any FP method that comes along as long as it is effective 4 
If the method has been recommended by the Pharmacy and Poisons Board we will procure it  1 
Total 2 
 













New product introduction strategies often suffer from a lack of available market research and rely on 
hypothetical approaches to gauge consumer demand. The PVR, as a new product in sub-Saharan Africa, 
also faces such a challenge. The Kenyan family planning program is largely a public sector program. 
Family planning services and contraceptives are offered free of charge in public sector facilities, and the 
government is the major source of contraceptives across the public, private-commercial, and private 
nonprofit sectors.   
To prepare for and facilitate the PVR’s eventual introduction into Kenya, we undertook this study to 
assess “Willingness to Pay,” “Willingness to Provide,” and “Willingness to Procure.” Findings generated on 
all three aspects are listed below.   
 Women seeking family planning services at public, nonprofit, and for-profit facilities are willing to 
pay for the PVR if it becomes available. A significant proportion of women who visit the private 
commercial sector spend KES50–199 per month on FP services and products. This implies that a 
market currently exists for FP products through the private commercial sector channel. 
 The majority of respondents were willing to pay a price equivalent to a three-month supply of POP 
(Microlut) as well as a 10% increment on the price, with some variation across sectors. 
Respondents from public sector facilities were more sensitive to marginal price increments than 
those who were interviewed at private sector facilities.   
 Nearly universally, health care providers (based in public, nonprofit, and private commercial 
facilities) indicated that the PVR is an important option to include in the choice of methods, 
especially in light of the frequent and prolonged stock-outs of Microlut. They are willing to counsel 
and provide it to users. Providers in the public and nonprofit sectors suggested a median price of 
KES100 (US$1), and those in the private commercial sector proposed a median price of KES200 
(US$2). 
 Procurers are willing to procure the PVR and make it available through their distribution networks 
and outlets. They are willing to purchase the PVR at much higher costs than what consumers had 
proposed.   
 All key stakeholders (women, providers, and procurers in public, nonprofit, and for-profit private 
sectors) were interested and supportive of the one-year ring. All those interviewed were willing to 
pay for the long-acting ring at higher costs than the PVR. The median price for the one-year ring 
varied across the sectors—100KES (US$1) in the public sector, 400KES (US$4) in the nonprofit 
private sector, and 500KES (US$5) in the private commercial sector.  
 There is potential for the private sector to play an active role in FP provision that can be utilized 
for the introduction of the PVR. This sector can serve the segment of customers that have 
expressed higher levels of willingness to pay for the PVR. Social marketing organizations and 
commercial players can ease the burden on public health expenditure while tapping into Kenya’s 





It is important to note that some of the target groups assessed, including a number of the facilities and 
health providers in the nonprofit private sector, had small sample sizes compared to public and for-profit 
private sector teams. The study highlights the ability of public sector consumers to afford FP products and 
the potential for serving them via private sector mechanisms.   
In terms of utilization, the results generated will inform and guide next steps about product introduction. 
Specifically, the findings of this study will be integrated with results from a market-segmentation exercise 
conducted earlier to develop a pricing model for the PVR. The price will reflect not only the COGS and cost 
of product introduction (training, educational material, marketing and branding, demand creation) but 
also the benefits to the health system (e.g., limited need for infrastructure and equipment, potential for 
multiple service outlets and health cadres). The results will also be useful to refine PVR market 
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